Effects of l-Histidine and Its Structural Analogues on Human N-Myristoyltransferase Activity and Importance of EEVEH Amino Acid Sequence for Enzyme Activity
- 1 October 1998
- journal article
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 37 (42) , 14928-14936
- https://doi.org/10.1021/bi980891b
Abstract
Myristoyl-CoA:protein N-myristoyltransferase (NMT) is an essential eukaryotic enzyme that catalyzes the cotranslational transfer of myristate to the NH2-terminal glycine residue of a number of important proteins of diverse function. Human NMT (hNMT) activity was found to be activated by l-histidine in a concentration-dependent manner. In contrast, two structural analogues of l-histidine, l-histidinol and histamine, inhibited hNMT activity in a noncompetitive manner with half-maximal inhibitions of 18 and 1.5 mM, respectively. The inhibition of hNMT activity by l-histidinol was reversed by a 2-fold molar excess of l-histidine, suggesting that l-histidine and l-histidinol were competing for a common site on NMT. Kinetic data indicated that whereas l-histidine enhanced the Vmax, both l-histidinol and histamine decreased the Vmax; none of these compounds altered the Km. Our studies suggest that l-histidine and its analogues may be interacting with His-293, involved in myristoyl-CoA transfer, rather than His-218, and implicated in the transfer of myristoyl-CoA to the peptide substrates. Site-directed mutagenesis of His-293, Val-291, and Glu-290 resulted in proteins with no measurable NMT activity. The most conserved region in the catalytic domain EEVEH (289−293) is critical for the myristoyl-CoA transfer in the NMT-catalyzed reactions. This region will be useful for the design of regulators of NMT function.Keywords
This publication has 13 references indexed in Scilit:
- A Second Mammalian N-MyristoyltransferaseJournal of Biological Chemistry, 1998
- Human N-Myristoyltransferase Amino-terminal Domain Involved in Targeting the Enzyme to the Ribosomal Subcellular FractionJournal of Biological Chemistry, 1997
- Design and Synthesis of Novel Imidazole-Substituted Dipeptide Amides as Potent and Selective Inhibitors of Candida albicans MyristoylCoA:Protein N-Myristoyltransferase and Identification of Related Tripeptide Inhibitors with Mechanism-Based Antifungal ActivityJournal of Medicinal Chemistry, 1997
- MyristoylationCellular Signalling, 1997
- Increased N-Myristoyltransferase Activity Observed in Rat and Human Colonic TumorsJNCI Journal of the National Cancer Institute, 1995
- Protein N-Myristoylation as a Chemotherapeutic Target for CancerJNCI Journal of the National Cancer Institute, 1995
- GENETIC AND BIOCHEMICAL STUDIES OF PROTEIN N-MYRISTOYLATIONAnnual Review of Biochemistry, 1994
- Comparison of myristoyl-CoA:protein N-myristoyltransferases from three pathogenic fungi: Cryptococcus neoformans, Histoplasma capsulatum, and Candida albicans.Published by Elsevier ,1994
- A comparative analysis of the kinetic mechanism and peptide substrate specificity of human and Saccharomyces cerevisiae myristoyl-CoA:protein N-myristoyltransferasePublished by Elsevier ,1993
- L-Histidinol improves the selectivity and efficacy of alkylating agents and daunomycin in mice with P388 leukaemiaBritish Journal of Cancer, 1989